A novel inducible acute hyperglycemia mouse model for assessing 6‑KTP

  • Authors:
    • Jinrui Hu
    • Xia Zhong
    • Xiaoping Yang
    • Hongjian Li
    • Yanhong Ran
  • View Affiliations

  • Published online on: July 8, 2019     https://doi.org/10.3892/br.2019.1228
  • Pages: 110-114
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to establish a mouse model of acute hyperglycemia, which may be utilized to detect the glucose concentration‑dependent hypoglycemic activity of the glucagon‑like peptide‑1 derivative, 6‑KTP. The results demonstrated that the first 30 min following the intraperitoneal injection of 2 g/kg glucose into C57BL/6J mice was the optimum time for assessing the hypoglycemic activity of potential therapeutic methods for diabetes. There was a linear association between the dose of 6‑KTP and hypoglycemic activity between 0.2 and 1.2 mg/kg. The resulting model may serve as template for developing cost‑effective in vivo models to test similar therapeutics.
View Figures
View References

Related Articles

Journal Cover

September 2019
Volume 11 Issue 3

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Hu, J., Zhong, X., Yang, X., Li, H., & Ran, Y. (2019). A novel inducible acute hyperglycemia mouse model for assessing 6‑KTP. Biomedical Reports, 11, 110-114. https://doi.org/10.3892/br.2019.1228
MLA
Hu, J., Zhong, X., Yang, X., Li, H., Ran, Y."A novel inducible acute hyperglycemia mouse model for assessing 6‑KTP". Biomedical Reports 11.3 (2019): 110-114.
Chicago
Hu, J., Zhong, X., Yang, X., Li, H., Ran, Y."A novel inducible acute hyperglycemia mouse model for assessing 6‑KTP". Biomedical Reports 11, no. 3 (2019): 110-114. https://doi.org/10.3892/br.2019.1228